Malin Corporation
Malin Corporation plc is an Irish public limited company established in 2015, with its headquarters in Dublin and additional offices in New Haven, Connecticut, and Research Triangle, North Carolina. The company specializes in venture capital investments, focusing on innovative enterprises within the life sciences and healthcare technology sectors, particularly in oncology, immunology, and genetic diseases. Malin's strategy involves the selective application of capital and operational expertise to support private, pre-IPO, and pre-trade sale businesses in rapidly growing markets. By actively engaging with its investee companies, Malin aims to enhance their value propositions and facilitate their journey toward commercial success.
Top Sectors
Top Regions
https://crunchbase.com/organization/***
https://linkedin.com/company/***
Past deals in North Carolina
Novan
Private Equity Round in 2015
Novan, Inc. is a clinical development-stage biotechnology company headquartered in Morrisville, North Carolina, focused on creating nitric oxide-based therapies for dermatological and oncovirus-mediated diseases. The company is engaged in the development of several clinical-stage dermatology product candidates, including SB204, a topical treatment for acne vulgaris; SB206, an anti-viral gel for viral skin infections; SB208, a broad-spectrum anti-fungal gel for skin and nail infections; and SB414, a topical cream for inflammatory skin diseases. Additionally, Novan is developing SB207, another topical anti-viral product candidate. By utilizing a proprietary technology platform that encapsulates nitric oxide in nano-particles, Novan aims to deliver therapeutic agents precisely to targeted areas in the body. Established in 2006, the company collaborates with strategic partners to advance its innovative therapies addressing unmet medical needs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.